Therefore, we postulated that membrane-bound ICAM-2 binds to cytoplasmic ezrin or α-actinin which, in turn, binds to actin to regulate the motility—and hence the metastatic potential—of neuroblastoma cells. Here, ICAM2 is linked to neuroblastoma.